2-218638390-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001379659.1(ZNF142):c.5613G>A(p.Glu1871=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0396 in 1,533,196 control chromosomes in the GnomAD database, including 1,583 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.056 ( 344 hom., cov: 32)
Exomes 𝑓: 0.038 ( 1239 hom. )
Consequence
ZNF142
NM_001379659.1 synonymous
NM_001379659.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.467
Genes affected
ZNF142 (HGNC:12927): (zinc finger protein 142) The protein encoded by this gene belongs to the Kruppel family of C2H2-type zinc finger proteins. It contains 31 C2H2-type zinc fingers and may be involved in transcriptional regulation. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 2-218638390-C-T is Benign according to our data. Variant chr2-218638390-C-T is described in ClinVar as [Benign]. Clinvar id is 1254978.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.467 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF142 | NM_001379659.1 | c.5613G>A | p.Glu1871= | synonymous_variant | 11/11 | ENST00000411696.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF142 | ENST00000411696.7 | c.5613G>A | p.Glu1871= | synonymous_variant | 11/11 | 5 | NM_001379659.1 | P1 | |
ZNF142 | ENST00000449707.5 | c.5013G>A | p.Glu1671= | synonymous_variant | 10/10 | 1 | |||
ZNF142 | ENST00000450765.5 | c.*4838G>A | 3_prime_UTR_variant, NMD_transcript_variant | 11/11 | 1 | ||||
ZNF142 | ENST00000433921.5 | c.*4838G>A | 3_prime_UTR_variant, NMD_transcript_variant | 11/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0564 AC: 8580AN: 152146Hom.: 343 Cov.: 32
GnomAD3 genomes
AF:
AC:
8580
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0454 AC: 8621AN: 189866Hom.: 272 AF XY: 0.0440 AC XY: 4423AN XY: 100558
GnomAD3 exomes
AF:
AC:
8621
AN:
189866
Hom.:
AF XY:
AC XY:
4423
AN XY:
100558
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0377 AC: 52103AN: 1380932Hom.: 1239 Cov.: 31 AF XY: 0.0378 AC XY: 25603AN XY: 676780
GnomAD4 exome
AF:
AC:
52103
AN:
1380932
Hom.:
Cov.:
31
AF XY:
AC XY:
25603
AN XY:
676780
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0564 AC: 8595AN: 152264Hom.: 344 Cov.: 32 AF XY: 0.0553 AC XY: 4118AN XY: 74448
GnomAD4 genome
AF:
AC:
8595
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
4118
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
242
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
ZNF142-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at